What did PaySauce Limited announce?
PaySauce Limited (NZX: PYS) filed “Capital Change Notice - ESS, Director Fees, RSU conversion” with NZX on 20 October 2026, as a capital change announcement.
- Which company?
- PaySauce Limited (NZX: PYS)
- When was it filed?
- 20 October 2026
- Where is the original?
- NZX announcement
Capital Change Notice - ESS, Director Fees, RSU conversion
Capital Change Notice
Section 1: Issuer information
Name of issuer PaySauce Limited
NZX ticker code PYS
Class of financial product Ordinary Shares
ISIN (If unknown, check on NZX website) N/A
Currency NZD
Section 2: Capital change details
Number issued 550,604
Nominal value (if any) N/A
Issue/acquisition/redemption price per security
1. and 2. $0.1966 per share
(being the Average Market
Price of a PYS share at the
date of allotment)
3. 0.2576 per share (being the
price of the Restricted Share
Units when issued)
Nature of the payment (for example, cash or other
consideration)
1. For 399,631 shares, cash.
2. For 57,223 shares, N/A.
3. For 93,750 shares, N/A
Amount paid up (if not in full) Fully Paid
Percentage of total class of Financial Products
issued/acquired/redeemed/ (calculated on the number of
Financial Products of the Class, excluding any Treasury Stock,
in existence)
0.33% of all ordinary shares
on issue in PYS
For an issue of Convertible Financial Products or Options, the
principal terms of Conversion (for example the Conversion
price and Conversion date and the ranking of the Financial
Product in relation to other Classes of Financial Product) or
the Option (for example, the exercise price and exercise date)
Reason for issue/acquisition/redemption and specific authority
for issue/acquisition/redemption/ (the reason for change must
be identified here)
1. 399,631 shares are issued
to employees as part of the
Quarterly Employee Share
Scheme, being issued to
staff for performance in Q2
of FY27.
2. 57,223 shares are issued to
Mark Samlal in lieu of
Directors Fees for the
quarter ended 30 Sept
2026.
3. 93,750 shares are issued to
Chris Ridd on vesting of the
same number of RSUs at a
price of $0.2576. The RSUs
vested on 30 Sept 2026,
being in lieu of 3 months of
services
Total number of Financial Products of the Class after the
issue/acquisition/redemption/Conversion (excluding Treasury
Stock) and the total number of Financial Products of the Class
held as Treasury Stock after the issue/acquisition/redemption.
167,023,391
In the case of an acquisition of shares, whether those shares
are to be held as treasury stock
N/A
Specific authority for the issue, acquisition, or redemption,
including a reference to the rule pursuant to which the issue,
acquisition, or redemption is made
Listing Rules 4.6 and 4.7 and
Board Resolutions.
Terms or details of the issue, acquisition, or redemption (for
example: restrictions, escrow arrangements)
The new shares will rank
equally with all other fully paid
ordinary shares on issue.
Date of issue/acquisition/redemption 20 Oct 2026
Section 3: Authority for this announcement and contact person
Name of person authorised to make this announcement Jaime Monaghan
Contact person for this announcement Jaime Monaghan
Contact phone number +64 22 5246 366
Contact email address jaime@paysauce.com
Date of release through MAP
21 Oct 2026
Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.
Other issuers discussed similar conditions around this time
Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.
- FPH — Fisher & Paykel Healthcare Corporation Limited: Capital Change Notice - Issue of Performance Share Rights2026-09-09
“Capital Change Notice 9 September 2026 Issue of Performance Share Rights This notice is given under NZX Listing Rule 3.13.1 and relates to unlisted Performance Share Rights to acquire ordinary shares in the Company (‘PSRs’) issued under the Fisher & Paykel Healthcare…”
- PHL — Promisia Healthcare Limited: Completion of Chatswood Acquisition2026-10-01
“pursuant to which the issue, acquisition, or redemption is made and approved by shareholders under Listing Rule 4.2.1. Terms or details of the issue, acquisition, or redemption (for example: restrictions, escrow arrangements) Issue of new Shares which rank equally with al…”
- SCL — Scales Corporation Limited: Capital Change Notice2026-09-24
“where the participant ceases to be employed by Scales before the vesting date (except in certain circumstances). Reason for issue/acquisition/redemption and specific authority for issue/acquisition/redemption/ (the reason for change must be identified here) Issue of 34,140…”